MT2

Melanotan 2 (MT2) is a synthetic cyclic peptide analog of alpha-melanocyte-stimulating hormone (α-MSH). It is primarily known in research for its role in modulating pigmentation through the activation of melanocortin receptors. Beyond its effects on melanin synthesis, it is frequently studied for its potential influence on central nervous system pathways, including appetite regulation and sexual arousal, making it a multifaceted tool for research into melanocortin receptor function. <br><br> The mechanism of action involves non-selective binding to several melanocortin receptor subtypes, specifically MC1R, MC3R, MC4R, and MC5R. Activation of MC1R in melanocytes leads to the production of eumelanin, which results in skin darkening. The central effects, such as appetite modulation and pro-sexual signaling, are attributed to the peptide's ability to cross the blood-brain barrier and activate MC4R in the hypothalamus. This multi-receptor profile is what differentiates it from more selective agents. <br><br> Research backing for Melanotan 2 spans dermatological, metabolic, and neurological studies. Early clinical trials investigated its efficacy for tanning and its role in treating sexual dysfunction, which eventually led to the development of more specialized melanocortin agonists. Laboratory studies continue to use MT2 to explore the molecular regulation of pigment synthesis, the neurobiology of motivation and reward pathways, and the systemic effects of MCR activation in various model systems.